India to Mauritius: Daratumumab Export Trade Route

The India to Mauritius Daratumumab corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $55.1K USD. The route is dominated by HUMANIQE BIOPHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's daratumumab manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $18.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 12.4%, placing it at rank #10 among India's top daratumumab export destinations globally.

On the import side, key buyers of Indian daratumumab in Mauritius include IBL LTD-HEALTHACTIV. IBL LTD-HEALTHACTIV is the single largest importer with 3 shipments valued at $55.1K USD.

India's daratumumab exports to Mauritius are driven primarily by a handful of large-scale manufacturers. HUMANIQE BIOPHARMACEUTICALS PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Mauritius benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — HUMANIQE BIOPHARMACEUTICALS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $18.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as darzalex faspro 1800mg daratumumab liquid for injection 1800mg batch no-nis6107mfg.dt-10/2023 exp.dt-09/2025, suggesting that buyers in Mauritius tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, IBL LTD-HEALTHACTIV is the largest importer with 3 shipments worth $55.1K USD — representing 100% of all daratumumab imports from India on this route.